RESUMO
Pycnodysostosis (MIM 265800) is a rare, autosomal recessive skeletal dysplasia characterized by short stature, wide cranial sutures, and increased bone density and fragility. Linkage analysis localized the disease gene to human chromosome 1q21, and subsequently the genetic interval was narrowed to between markers D1S2612 and D1S2345. Expressed sequence tagged markers corresponding to cathepsin K, a cysteine protease highly expressed in osteoclasts and thought to be important in bone resorption, were mapped previously in the candidate region. We have identified a cytosine to thymidine transition at nucleotide 862 (GenBank accession no. S79895) of the cathepsin K coding sequence in the DNA of an affected individual from a large, consanguinous Mexican family. This mutation results in an arginine to STOP alteration at amino acid 241, predicting premature termination of cathepsin K mRNA translation. All affected individuals in this family were homozygous for the mutation, suggesting that this alteration may lead to pycnodysostosis. Recognition of the role of cathepsin K in the etiology of pycnodysostosis should provide insights into the pathogenesis and treatment of other disorders of bone remodeling, including osteoporosis.
Assuntos
Doenças do Desenvolvimento Ósseo/genética , Catepsinas/genética , Mutação/genética , Southern Blotting , Doenças do Desenvolvimento Ósseo/fisiopatologia , Catepsina K , Catepsinas/química , Mapeamento Cromossômico , Cromossomos Humanos Par 1/genética , Códon sem Sentido/genética , Consanguinidade , Primers do DNA/química , Doenças Genéticas Inatas/genética , Ligação Genética/genética , Marcadores Genéticos/genética , Humanos , Escore Lod , México , Dados de Sequência Molecular , Linhagem , Análise de SequênciaRESUMO
Ellis-van Creveld syndrome (EVC) is an autosomal recessive disorder characterized by disproportionate dwarfism, polydactyly, and congenital heart disease. This rare disorder is found with increased frequency among the Old Order Amish community in Lancaster County, Pennsylvania. We have used linkage analysis to localize the gene responsible for the EVC phenotype in nine interrelated Amish pedigrees and three unrelated families from Mexico, Ecuador, and Brazil. We now report the linkage for the Ellis-van Creveld syndrome gene to markers on the distal short arm of human chromosome 4, with Zmax = 6.91 at theta = 0.02 for marker HOX7, in a region proximal to the FGFR3 gene responsible for the achondroplasia phenotype.
Assuntos
Cromossomos Humanos Par 4/genética , Síndrome de Ellis-Van Creveld/genética , Etnicidade/genética , Brasil/epidemiologia , Mapeamento Cromossômico , Consanguinidade , Equador/epidemiologia , Síndrome de Ellis-Van Creveld/etnologia , Genes Recessivos , Ligação Genética , Haplótipos/genética , Humanos , México/epidemiologia , Linhagem , Pennsylvania/epidemiologiaRESUMO
The genomic DNAs of carrier mothers from 20 hemophilia A unrelated Mexican families were analysed by polymerase chain reaction (PCR) amplification of the Bcl I polymorphic region at intron 18 of the factor VIII gene. Eleven women (55%) were found to be informative (Bcl I+/Bcl I-), eight (40%) were Bcl I- homozygotes and one (5%) was a Bcl I+ homozygote. In 18 daughters of the informative families we were able to establish carrier status for eight. The frequency of the Bcl I alleles in the 20 mothers was 0.675 for Bcl I- and 0.325 for Bcl I+ which give a frequency of 44% of heterozygous females in our sample.
Assuntos
Hemofilia A/genética , Feminino , Heterozigoto , Homozigoto , Humanos , Masculino , México , LinhagemRESUMO
Thirteen dogs naturally infected with Leishmania infantum showing viscerocutaneous signs of disease were treated with different dosages of liposomal amphotericin B (AmBisome) 3-3.3 kg showed rapid clinical improvement, with regression of lymphadenomegaly and splenomegaly, and cure of skin lesions. The clinical response was similar to that obtained with 14-21 doses of conventional antileishmanial drugs. However, follow-up lymph node aspirates remained positive for Leishmania in all dogs except one, which was treated with the total dose ofAmBisome 15 mg kg. The failure in parasitological cure may be due to inadequate drug targeting to parasitized cells, or to T-cell immune depression characteristic of patent cases of canine leishmaniasis, or to both